Endonovo Therapeutics Issues Shareholder Letter and Update
11. Januar 2019 09:15 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapeutic...